MogensenCE.Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetics. N Engl J Med.1984; 310: 66.
3.
HaffnerSMSteinMBGruberKKHazudaHPMitchellBDPattersonJK.Microalbuminuria: potential marker for increased cardiovascular risk factors in non-diabetic subjects?Arteriosclerosis1990; 10: 727–31.
4.
CastelliWP.Lipids, risk factors and ischaemic heart disease. Atherosclerosis1996; 124: S1–S9.
5.
AssmanGSchulteHCullenP.New and classic risk factors — Munster heart study (PROCAM). Eur J Med Res.1997; 6: 237–42.
6.
NyuyenTTElleformRDHodgeDOBallesKRKoltheTEAbu-LeddhlLp(a) as a risk factor for cardiovascular disease. Circulation1997; 96: 1390–7.
7.
HeinrichJBailiesenLSchulteHAssmanGVan de LooJ.Fibrinogen and factor VII as predictors of coronary infarction in healthy men. PROCAM Study. Atheroscler Thromb1994; 14: 52–60.
8.
KarnalWBWolfPACastelliWPD'AgostinoRB.Fibrinogen and risk of cardiovascular disease: Framingham Study. J Am Med Assoc1987; 258: 1183–9.
9.
BranchiARoveliniASommarivaDGugliandroloAGFasoliA.Effects of 3 fibrate derivatives and of 3 HMG CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolaemia. Thromb Haemost1993; 70: 241.
10.
DaneshJCollinsRPetoR.Chronic infections and coronary heart disease: is there a link?Lancet1997; 350: 430–5.
11.
PerryIJRefsumHMorrisRWEbrahimSBUelandPMShaperAG.Prospective study of serum homocysteine concentration and risk of stroke in middle-aged British men. Lancet1995; 346: 1395–8.
12.
StampferMJMalinowMRWilletWCA prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc1992; 24: 877–81.
13.
MalinowMR.Homocysteine and arterial occlusive diseases. J Intern Med.1994; 236: 603–17.
14.
StamlerJS.Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev.1996; 54: 1–30.
15.
BrattstromL.Vitamins as homocysteine-lowering agents. J Nutr1996; 126: 1276S–80S.
16.
de WardenerHE.The Kidney. Edinburgh: Churchill Livingstone, 1985: 49–50.
17.
WallerKVWardKMMakenJDWismattDKJ.Current concepts in proteinuria. Clin Chem1989; 35: 755–65.
18.
DeenWMMyersBDBrennerBM.The glomerular barrier to macromolecules: theoretical and experimental considerations. In: BrennerBMSteinJA, eds. Nephrotic Syndrome. New York: Churchill Livingstone; 1982: 8–9.
19.
ParkCHMaackT.Albumin absorption and catabolism by isolated perfused convoluted tubules of the rabbit. J Clin Invest1984; 73: 767–77.
20.
GoslingPBeeversDG.Urinary albumin excretion in the general population. Clin Sci.1989; 76: 39–42.
21.
WestJNGoslingPDimmitSBLittlerWA.Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci.1991; 81: 373–7.
22.
PontrmoliRSofiaATirottaARaveraMNicotellaCViazziFThe deletion polymorphism of the angiotensin-1 converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol1996; 7: 2250–8.
23.
DeckertTKofoed-EnevoldsenAVidelPNorgaardKAndreasenHBFeldt-RasmussenB.Size and charge selection in glomerular filtration in Type 1 diabetic patients with and without albuminuria. Diabetologia1993; 36: 244–51.
24.
Kofoed-EnevoldsenAFoyleWJFernandezMYudkinJS.Evidence of impaired glomerular charge selectivity in non-diabetic patients with microalbuminuria: relevance to cardiovascular disease. Arterioscler Thromb Vasc Biol1996; 16: 450–4.
25.
ParvingHHJensenMMorgensenCEEvrinPE.Increased urinary albumin excretion rate in benign essential hypertension. Lancet1974; i: 1190–2.
26.
Felt-RasmussenB.Increased transcapillary escape rate of albumin in type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia1989; 32: 219–26.
27.
YudkinJS.Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease. Ann Med.1996; 28: 433–8.
28.
StehouwerCDAFischerHRVan KuijkAWPolakBCDonkerAJM.Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes1995; 44: 561–4.
RoineI.Microalbuminuria: an index of severity in childhood meningitis. Pediatr Infect Dis J1993; 12: 584–8.
31.
PedersenLMNordinHSvenssonBBliddalH.Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis.1995; 54: 189–92.
32.
MahmoodNStinsonJO'ConnellMFeeleyJWeirGDKelleherD.Microalbuminuria: a disease activity marker for inflammatory bowel disease. Gut1993; 34: S24.
33.
ShearmanCPGoslingPWalkerKJ.Is low level proteinuria a predictor of severity in acute pancreatitis?J Clin Pathol1989; 42: 1132–5.
34.
PalisterIGoslingPAlparKBradleyS.Prediction of post traumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. J Trauma1997; 42: 1056–61.
35.
SmithFCTGoslingPSangheraKGreenMCPatersonISShearmanCP.Microproteinuria predicts the severity of systemic effects of reperfusion injury following infra-renal aortic aneurysm surgery. Ann Vasc Surg1994; 8: 1–5.
36.
GoslingPHughesEAReynoldsTMFoxJP.Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J1991; 12: 508–13.
37.
HortonRCGoslingPReevesCNPayneMNagleRE.Microalbumin excretion in patients with positive exercise electrocardiogram tests. Eur Heart J1994; 15: 1353–55.
38.
HickeyNCShearmanCPGoslingPSimmsMH.Assessment of intermittent claudication by quantitative exercise-induced microalbuminuria. Eur J Vasc Surg1994; 15: 603–6.
39.
HickeyNCGoslingPBaarSShearmanCPSimmsMH.Effect of surgery on the systemic inflammatory response to intermittent claudication. Br J Surg 1009; 77: 1121–4.
40.
AgrawalBBergerAWolfKLuftFC.Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens1996; 14: 223–8.